why choose us

First received: December 12, 2022

Clinical Trial: Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Multiple Sclerosis

Study Type: OBSERVATIONAL


Official Title: Vumerity (Diroximel Fumarate) Prospective MS Pregnancy Exposure Registry

Brief Summary: The primary objectives of the study are to estimate the risk of major congenital malformations (MCMs) in infants born to women with multiple sclerosis (MS) who were exposed to diroximel fumarate (DRF) at any time from 2 weeks after the first day of their last menstrual period (LMP) up through the first trimester of pregnancy and to comparatively evaluate pregnancy outcomes with MCMs in women with MS who were exposed to DRF at any time from 2 weeks after the first day of their LMP through the first trimester of…

Read more